Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Remodeling

NCT05606718 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Functional Mitral Regurgitation

Interventions

DRUG: Dapagliflozin
OTHER: guideline-directed medical therapy (GDMT)

Sponsor

Sun Yat-sen University